Discussions

Protacs technology has evolved at a rapid pace in recent years and has entered an unprecedented phase. The advantage of this technology is that it not only converts non-drug targets (non-druggable) into viable drug targets (druggable), but also solves the problem of drug resistance of existing targets. Our Protac products are better able to help our customers by addressing their different needs, as well as establishing analytical methods and performing biological evaluations.

See our Protac Linker Screening